State Street’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Sell
543,863
-20,403
-4% -$149K ﹤0.01% 3031
2025
Q4
$3.46M Sell
564,266
-481,415
-46% -$5.2M ﹤0.01% 3140
2025
Q3
$19.3M Buy
1,045,681
+25,907
+3% +$416K ﹤0.01% 2276
2025
Q2
$13.3M Sell
1,019,774
-260,677
-20% -$3.08M ﹤0.01% 2425
2025
Q1
$13.6M Sell
1,280,451
-45,707
-3% -$726K ﹤0.01% 2338
2024
Q4
$22.5M Sell
1,326,158
-146,797
-10% -$2.76M ﹤0.01% 2165
2024
Q3
$34.2M Sell
1,472,955
-50,883
-3% -$1.09M ﹤0.01% 1894
2024
Q2
$37.1M Sell
1,523,838
-436,098
-22% -$13.2M ﹤0.01% 1815
2024
Q1
$66.2M Buy
1,959,936
+330,270
+20% +$11.7M ﹤0.01% 1564
2023
Q4
$51.4M Sell
1,629,666
-38,259
-2% -$909K ﹤0.01% 1691
2023
Q3
$42.6M Sell
1,667,925
-316,243
-16% -$9.74M ﹤0.01% 1718
2023
Q2
$56.9M Sell
1,984,168
-253,831
-11% -$6.91M ﹤0.01% 1590
2023
Q1
$53.6M Sell
2,237,999
-19,847
-0.9% -$356K ﹤0.01% 1616
2022
Q4
$38.3M Sell
2,257,846
-472,616
-17% -$8.24M ﹤0.01% 1821
2022
Q3
$40.5M Sell
2,730,462
-76,456
-3% -$1.28M ﹤0.01% 1752
2022
Q2
$44.2M Sell
2,806,918
-411,039
-13% -$8.07M ﹤0.01% 1732
2022
Q1
$86.8M Buy
3,217,957
+1,161,883
+57% +$29.6M ﹤0.01% 1393
2021
Q4
$76.1M Buy
2,056,074
+585,733
+40% +$23.9M ﹤0.01% 1518
2021
Q3
$70.3M Sell
1,470,341
-285,313
-16% -$12.8M ﹤0.01% 1548
2021
Q2
$59.4M Buy
1,755,654
+357,619
+26% +$12.1M ﹤0.01% 1718
2021
Q1
$57.7M Buy
1,398,035
+386,116
+38% +$23M ﹤0.01% 1633
2020
Q4
$43.9M Sell
1,011,919
-548,335
-35% -$37.1M ﹤0.01% 1719
2020
Q3
$66.9M Buy
1,560,254
+1,302,232
+505% +$64.6M ﹤0.01% 1239
2020
Q2
$12.1M Buy
+258,022
New +$8.89M ﹤0.01% 2317

Other funds holding ARCT